Test Catalog

Treponema pallidum, Antibodies (IgG+IgM). Screening

Clinical information

Diagnostic Utility:

This is the qualitative detection of IgG/IgM antibodies against Treponema pallidum (TP) and its determination is useful in:

  • Detection of exposure to Treponema Pallidum causing Syphilis.
  • Transfusion of blood components.
  • Transplantation of progenitor cells, umbilical cord blood, solid organs.
  • In egg and semen donors.

Method:

Chemiluminescence Microparticle Immunoassay (CMIA).

Reference Values

Possible results are: Reactive and Non-Reactive.

Diagnostic Algorithm:

In the case of a reactive Syphilis TP result, a confirmatory IgG antibody test can be requested by Immunoblot:

Code Test Name Can it be requested separately? Is it always done?
0134 Treponema pallidum, IgG. Confirmation by Immunoblot. NO NO (*)

(*) Only performed upon request.

Turnaround Time:

Maximum 2 working days

Specimen information

Sample: Serum and/or plasma
Tube: Aliquots of 1-5 mL, plasma tubes with EDTA, heparin, or sodium citrate as anticoagulant and/or serum tubes with or without separator.
Minimum essential volume: 1 ml
Stability:

  • At room temperature: ≤ 1 day
  • Refrigerated 2-8 ºC: ≤ 7 days
  • Sample frozen at or below -20ºC: 10 years

Transport instructions: Preferably at room temperature if it is whole blood tubes and refrigerated if it is serum and/or plasma aliquots.

Reason for rejection: Sample with a lot of hemolysis.

Administrative information

BST Code: 0131
Test Description: Treponema pallidum, Antibodies (IgG+IgM).
Synonyms: Syphilis TP
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.

Profiles:

Not applicable.

References

  • Inserts kits de Sifilis TP Architect, Abbott.

Quality

BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.